The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cost of poor adherence to anti-hypertensive therapy in five European countries
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877
RetractedGeneral Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 9×
“The estimation of risk and of the number of CV events related to hypertension was based on a well-known cohort study—the Framingham Heart Study—that consists of a non-European population, [15, 17] and no adjustments were made for ethnic composition in each country.”
BackgroundMethodInfluentialMedication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 2×
“different studies which could have used definitions different to that given in our study [16].”
BackgroundResultDiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“Existing research shows that in several European countries\60 % of treated hypertensive subjects have an adherence to their treatment over 80 % [10–14].”
BackgroundPrevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000252676.46043.18 · Cited by 1,395 · cited 2×
“The treatment of hypertension, one of the main risk factors, reduces the number of adverse cardiovascular events and thus decreases the economic and health impact of hypertension related CV [4–6].”
Background
Cited by
Current Situation of Medication Adherence in Hypertension
Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00100 · Cited by 292
Risk Factors for Nonadherence to Antihypertensive Treatment
Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C. M. J., Petrák, O., Gulsin, G. S., Patel, V., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08729 · Cited by 256
Fletcher, B. R., Hartmann-Boyce, J., Hinton, L., & McManus, R. J. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv008 · Cited by 193
Drug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111
Metadata
- Authors
- Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M. G., Gray, A., Levy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A., & Schmieder, R. E.
- Venue
- The European Journal of Health Economics
- Published
- 2014-01-05
- Volume
- 16
- Issue
- 1
- Pages
- 65-72
- ISSN
- 1439-3972 (ISSN-L)
- 1618-7598
- 1618-7601
- OpenAlex
- W1498155216
- Cited by
- 215
- References
- 5
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost of poor adherence to anti-hypertensive therapy in five European countries. https://app.cochat.ai/papers/10.1007/s10198-013-0554-4
- The paper
- Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M. G., Gray, A., Levy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A., & Schmieder, R. E. (2015). Cost of poor adherence to anti-hypertensive therapy in five European countries. The European Journal of Health Economics. https://doi.org/10.1007/s10198-013-0554-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.